{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,31]],"date-time":"2026-05-31T21:00:32Z","timestamp":1780261232088,"version":"3.54.0"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100012478","name":"Secretaria de Ciencia y Tecnolog\u00eda - Universidad Nacional de C\u00f3rdoba","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012478","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010442","name":"Universidad Nacional de Cordoba","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010442","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002923","name":"Consejo Nacional de Investigaciones Cient\u00edficas y T\u00e9cnicas","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002923","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007868","name":"Secretar\u00eda de Ciencia y T\u00e9cnica, Universidad Nacional de R\u00edo Cuarto","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007868","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry Letters"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.bmcl.2026.130689","type":"journal-article","created":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T15:15:44Z","timestamp":1779290144000},"page":"130689","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Synthesis and preliminary enzymatic evaluation of polyol-based 4-phenylbutyrate derivatives"],"prefix":"10.1016","volume":"138","author":[{"given":"Laura","family":"Suchetti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomas C.","family":"Tempesti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Ferrayoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmcl.2026.130689_bb0005","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.phrs.2019.04.002","article-title":"Lipid-regulating properties of butyric acid and 4-phenylbutyric acid: molecular mechanisms and therapeutic applications","volume":"144","author":"He","year":"2019","journal-title":"Pharmacol Res"},{"issue":"2","key":"10.1016\/j.bmcl.2026.130689_bb0010","doi-asserted-by":"crossref","first-page":"197","DOI":"10.4161\/pri.28938","article-title":"The therapeutic potential of chemical chaperones in protein folding diseases","volume":"8","author":"Cortez","year":"2014","journal-title":"Prion"},{"issue":"6\u20137","key":"10.1016\/j.bmcl.2026.130689_bb0015","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1080\/15592294.2019.1700032","article-title":"4-phenylbutyric acid promotes migration of gastric cancer cells by histone deacetylase inhibition-mediated IL-8 upregulation","volume":"15","author":"Shi","year":"2020","journal-title":"Epigenetics"},{"issue":"4","key":"10.1016\/j.bmcl.2026.130689_bb0020","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.379","article-title":"4-phenylbutyric acid promotes hepatocellular carcinoma via initiating cancer stem cells through activation of PPAR-\u03b1","volume":"11","author":"Chen","year":"2021","journal-title":"Clin Transl Med"},{"issue":"10","key":"10.1016\/j.bmcl.2026.130689_bb0025","doi-asserted-by":"crossref","first-page":"3546","DOI":"10.1016\/j.bbadis.2018.08.014","article-title":"Chemical chaperone 4-phenylbutyric acid alleviates the aggregation of human familial pulmonary fibrosis-related mutant SP-A2 protein in part through effects on GRP78","volume":"1864","author":"Jiang","year":"2018","journal-title":"Biochim Biophys Acta (BBA)-Mol Basis Dis"},{"issue":"1","key":"10.1016\/j.bmcl.2026.130689_bb0030","doi-asserted-by":"crossref","first-page":"11878","DOI":"10.1038\/s41598-021-91311-2","article-title":"4-phenylbutyrate (PBA) treatment reduces hyperglycemia and islet amyloid in a mouse model of type 2 diabetes and obesity","volume":"11","author":"de Pablo","year":"2021","journal-title":"Sci Rep"},{"issue":"4","key":"10.1016\/j.bmcl.2026.130689_bb0035","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.jpha.2022.04.001","article-title":"Human islet amyloid polypeptide: a therapeutic target for the management of type 2 diabetes mellitus","volume":"12","author":"Roham","year":"2022","journal-title":"J Pharm Anal"},{"issue":"3","key":"10.1016\/j.bmcl.2026.130689_bb0040","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1080\/13813455.2019.1628069","article-title":"4-Phenylbutyric acid and rapamycin improved diabetic status in high fat diet\/streptozotocin-induced type 2 diabetes through activation of autophagy","volume":"127","author":"Gadallah","year":"2021","journal-title":"Arch Physiol Biochem"},{"issue":"1","key":"10.1016\/j.bmcl.2026.130689_bb0045","doi-asserted-by":"crossref","first-page":"108","DOI":"10.5603\/ep.101404","article-title":"4-phenylbutyric acid attenuates diabetes mellitus secondary to thiamine-responsive megaloblastic anaemia syndrome by modulating endoplasmic reticulum stress","volume":"76","author":"Qin","year":"2025","journal-title":"Endokrynologia Polska"},{"issue":"3","key":"10.1016\/j.bmcl.2026.130689_bb0050","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.bbrc.2017.01.106","article-title":"4-PBA reverses autophagic dysfunction and improves insulin sensitivity in adipose tissue of obese mice via Akt\/mTOR signaling","volume":"484","author":"Guo","year":"2017","journal-title":"Biochem Biophys Res Commun"},{"issue":"5","key":"10.1016\/j.bmcl.2026.130689_bb0055","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1080\/10409238.2021.1925219","article-title":"Mechanisms linking endoplasmic reticulum (ER) stress and microRNAs to adipose tissue dysfunction in obesity","volume":"56","author":"Menikdiwela","year":"2021","journal-title":"Crit Rev Biochem Mol Biol"},{"issue":"2","key":"10.1016\/j.bmcl.2026.130689_bb0060","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1007\/s11325-018-1739-y","article-title":"4-phenylbutyric acid attenuates endoplasmic reticulum stress-mediated apoptosis and protects the hepatocytes from intermittent hypoxia-induced injury","volume":"23","author":"Xin","year":"2019","journal-title":"Sleep Breath"},{"issue":"4","key":"10.1016\/j.bmcl.2026.130689_bb0065","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1111\/acer.13982","article-title":"The chemical chaperone 4-Phenylbutyric acid prevents alcohol-induced liver injury in obese KK-ay mice","volume":"43","author":"Suzuki","year":"2019","journal-title":"Alcohol Clin Exp Res"},{"issue":"4","key":"10.1016\/j.bmcl.2026.130689_bb0070","doi-asserted-by":"crossref","first-page":"396","DOI":"10.3390\/antiox14040396","article-title":"Evaluation of additive neuroprotective effect of combination therapy for Parkinson's disease using in vitro models","volume":"14","author":"Shtilbans","year":"2025","journal-title":"Antioxidants"},{"key":"10.1016\/j.bmcl.2026.130689_bb0075","series-title":"stem cell-based therapy for neurodegenerative diseases","first-page":"117","article-title":"Cell-based therapy for spinal muscular atrophy","author":"Han","year":"2020"},{"issue":"2","key":"10.1016\/j.bmcl.2026.130689_bb0080","doi-asserted-by":"crossref","first-page":"298","DOI":"10.3390\/ph16020298","article-title":"Quantification of the chemical chaperone 4-Phenylbutyric acid (4-PBA) in cell culture media via LC-HRMS: applications in fields of neurodegeneration and cancer","volume":"16","author":"Villani","year":"2023","journal-title":"Pharmaceuticals"},{"issue":"19","key":"10.1016\/j.bmcl.2026.130689_bb0085","doi-asserted-by":"crossref","first-page":"3563","DOI":"10.1021\/acschemneuro.4c00472","article-title":"The Antiproteinopathy, antioxidant, and antiapoptotic effects of methylene blue and 4-Phenylbutyric acid alone, and in combination on familial Alzheimer's disease PSEN1 I416T cholinergic-like neurons","volume":"15","author":"Gomez-Sequeda","year":"2024","journal-title":"ACS Chem Neurosci"},{"key":"10.1016\/j.bmcl.2026.130689_bb0090","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.bbrc.2023.06.064","article-title":"4-Phenylbutyric acid attenuates amyloid-\u03b2 proteotoxicity through activation of HSF-1 in an Alzheimer\u2019s disease model of the nematode Caenorhabditis elegans","volume":"673","author":"Baumanns","year":"2023","journal-title":"Biochem Biophys Res Commun"},{"issue":"8","key":"10.1016\/j.bmcl.2026.130689_bb0095","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1002\/chem.201904292","article-title":"A lipophilic 4-phenylbutyric acid derivative that prevents aggregation and retention of misfolded proteins","volume":"26","author":"Azoulay-Ginsburg","year":"2020","journal-title":"Chem Eur J"},{"issue":"7","key":"10.1016\/j.bmcl.2026.130689_bb0100","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s40261-024-01371-1","article-title":"Sodium phenylbutyrate and tauroursodeoxycholic acid: a story of hope turned to disappointment in amyotrophic lateral sclerosis treatment","volume":"44","author":"Ketabforoush","year":"2024","journal-title":"Clin Drug Investig"},{"key":"10.1016\/j.bmcl.2026.130689_bb0105","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ejps.2017.04.018","article-title":"Phenyl butyrate inhibits pyruvate dehydrogenase kinase 1 and contributes to its anti-cancer effect","volume":"110","author":"Zhang","year":"2017","journal-title":"Eur J Pharm Sci"},{"issue":"14","key":"10.1016\/j.bmcl.2026.130689_bb0110","doi-asserted-by":"crossref","first-page":"9955","DOI":"10.1021\/acs.jmedchem.2c00640","article-title":"A mitochondria-targeted Phenylbutyric acid prodrug confers drastically improved anticancer activities","volume":"65","author":"Huang","year":"2022","journal-title":"J Med Chem"},{"issue":"3","key":"10.1016\/j.bmcl.2026.130689_bb0115","doi-asserted-by":"crossref","first-page":"227","DOI":"10.2165\/11591280-000000000-00000","article-title":"Clinical and experimental applications of sodium phenylbutyrate","volume":"11","author":"Iannitti","year":"2011","journal-title":"Drugs in R & D"},{"key":"10.1016\/j.bmcl.2026.130689_bb0120","first-page":"43","article-title":"Barriers to drug adherence in the treatment of urea cycle disorders: assessment of patient, caregiver and provider perspectives","volume":"8","author":"Shchelochkov","year":"2016","journal-title":"Mol Genet Metabol Rep"},{"issue":"12","key":"10.1016\/j.bmcl.2026.130689_bb0125","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1080\/21678707.2017.1405807","article-title":"Glycerol phenylbutyrate for the maintenance treatment of patients with deficiencies in enzymes of the urea cycle","volume":"5","author":"Longo","year":"2017","journal-title":"Expert Opin Orphan Drugs"},{"issue":"4","key":"10.1016\/j.bmcl.2026.130689_bb0130","doi-asserted-by":"crossref","DOI":"10.1002\/slct.202304021","article-title":"An alternative pathway for the synthesis of glycerol phenylbutyrate","volume":"9","author":"Suchetti","year":"2024","journal-title":"ChemistrySelect"},{"key":"10.1016\/j.bmcl.2026.130689_bb0135","unstructured":"Process for the preparation of glycerol phenilbutyrate. Publication Number WO\/2015\/063659. Publication Date 07.05.2015."},{"key":"10.1016\/j.bmcl.2026.130689_bb0140","unstructured":"Glycerol phenyl butyrate esters. Publication Number EP 2 607 366 A. Publication data: 26.06.2013."},{"issue":"2","key":"10.1016\/j.bmcl.2026.130689_bb0145","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1021\/acs.jchemed.3c00811","article-title":"An expedient undergraduate synthesis of glycerol phenylbutyrate, one of the most expensive medications in the United States","volume":"101","author":"Yazzie","year":"2024","journal-title":"J Chem Educ"},{"key":"10.1016\/j.bmcl.2026.130689_bb0150","unstructured":"Food and Drug Administration. PART 182 Substances generally recognized as safe. Subpart A\u2014General Provisions. Sec, 182; 2011."},{"key":"10.1016\/j.bmcl.2026.130689_bb0155","series-title":"Handbook of pharmaceutical excipients","author":"Rowe","year":"2020"}],"container-title":["Bioorganic & Medicinal Chemistry Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X26001563?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X26001563?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,31]],"date-time":"2026-05-31T20:02:54Z","timestamp":1780257774000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960894X26001563"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":31,"alternative-id":["S0960894X26001563"],"URL":"https:\/\/doi.org\/10.1016\/j.bmcl.2026.130689","relation":{},"ISSN":["0960-894X"],"issn-type":[{"value":"0960-894X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthesis and preliminary enzymatic evaluation of polyol-based 4-phenylbutyrate derivatives","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmcl.2026.130689","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"130689"}}